Lab
Toledo Clinic Incorporated
Toledo Clinic Incorporated was paid $1.98M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 9.1% of everything it billed.
33Billing provider infoTOLEDO CLINIC INCORPORATED
TOLEDO, OH 43623
TOLEDO, OH 43623
33aNPI1114079167assigned 01/18/2007
33bProvider typeClinical Medical Laboratory
28Total paid$1.98M
24GClaims335,867
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Ohio
Rank by total paid#34 of 116
Median peer was paid$313K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,781 | $231K | |
| 2019 | 34,994 | $247K | |
| 2020 | 35,115 | $244K | |
| 2021 | 48,957 | $343K | |
| 2022 | 53,745 | $351K | |
| 2023 | 71,406 | $264K | |
| 2024incomplete | 61,869 | $304K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9.1% | 10,854 | 9,965 | $181K |
| 80053 | Comprehensive metabolic panel | 6.4% | 28,083 | 23,854 | $127K |
| 80061 | Lipid panel | 5.1% | 15,292 | 14,216 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.1% | 29,761 | 24,540 | $102K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.1% | 15,054 | 13,574 | $101K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.1% | 2,392 | 2,231 | $81K |
| 86235 | 3.6% | 1,154 | 1,085 | $72K | |
| 36415 | Collection of venous blood by venipuncture | 3.3% | 32,108 | 25,587 | $66K |
| 82607 | 3.0% | 7,147 | 6,572 | $59K | |
| 84439 | 2.8% | 10,762 | 9,910 | $56K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 804 | 757 | $51K |
| 82728 | 2.4% | 6,594 | 6,064 | $48K |
96 more codes
| 84481 | 2.3% | 4,427 | $45K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.2% | 9,880 | $45K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.1% | 354 | $42K |
| 82746 | 1.9% | 4,904 | $38K | |
| 80050 | General health panel | 1.9% | 2,081 | $38K |
| 83970 | 1.6% | 1,825 | $31K | |
| 84153 | 1.5% | 2,757 | $30K | |
| 83550 | 1.5% | 6,366 | $29K | |
| 82784 | 1.4% | 2,742 | $29K | |
| 85027 | 1.3% | 7,601 | $27K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 1,021 | $25K |
| 86140 | 1.2% | 8,599 | $24K | |
| 83540 | 1.2% | 6,824 | $24K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 6,105 | $23K |
| 86003 | 1.1% | 282 | $23K | |
| 81001 | <1% | 10,545 | $19K | |
| 86225 | <1% | 2,200 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 574 | $17K |
| 83735 | <1% | 5,096 | $17K | |
| 82550 | <1% | 4,911 | $17K | |
| 86160 | <1% | 1,312 | $16K | |
| 86039 | <1% | 2,238 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,358 | $14K |
| 82570 | <1% | 5,880 | $13K | |
| 86376 | <1% | 1,355 | $13K | |
| 85652 | <1% | 8,128 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 565 | $12K |
| 80069 | <1% | 1,471 | $12K | |
| 82043 | <1% | 4,659 | $12K | |
| 86320 | <1% | 1,033 | $12K | |
| 82565 | <1% | 4,727 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 796 | $11K |
| 86800 | <1% | 1,061 | $11K | |
| 86803 | <1% | 1,467 | $10K | |
| 80076 | <1% | 2,176 | $10K | |
| 84460 | <1% | 4,115 | $10K | |
| 82785 | <1% | 942 | $10K | |
| 84450 | <1% | 4,002 | $10K | |
| 83525 | <1% | 1,263 | $9K | |
| 84165 | <1% | 1,752 | $9K | |
| 80074 | <1% | 309 | $8K | |
| 83516 | <1% | 477 | $8K | |
| 84075 | <1% | 3,353 | $8K | |
| 86706 | <1% | 1,286 | $8K | |
| 82040 | <1% | 3,412 | $8K | |
| 87340 | <1% | 1,333 | $8K | |
| 87077 | <1% | 1,786 | $8K | |
| 84550 | <1% | 3,384 | $7K | |
| 84403 | <1% | 438 | $7K | |
| 86431 | <1% | 1,690 | $6K | |
| 83615 | <1% | 2,033 | $6K | |
| 86704 | <1% | 949 | $6K | |
| 87186 | <1% | 1,248 | $5K | |
| 86200 | <1% | 618 | $5K | |
| 85610 | <1% | 2,234 | $4K | |
| 82103 | <1% | 589 | $4K | |
| 82310 | <1% | 1,731 | $4K | |
| 84100 | <1% | 1,851 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 165 | $3K |
| 86038 | <1% | 482 | $3K | |
| 86769 | <1% | 84 | $3K | |
| 83883 | <1% | 241 | $2K | |
| 84703 | <1% | 298 | $2K | |
| 82105 | <1% | 226 | $2K | |
| 86708 | <1% | 268 | $2K | |
| 83690 | <1% | 457 | $2K | |
| 84156 | <1% | 953 | $2K | |
| 87430 | <1% | 151 | $2K | |
| 83001 | <1% | 113 | $1K | |
| 85651 | <1% | 392 | $1K | |
| 84146 | <1% | 68 | $843.39 | |
| 85046 | <1% | 314 | $836.70 | |
| 83002 | <1% | 71 | $783.63 | |
| 86780 | <1% | 81 | $642.53 | |
| 85730 | <1% | 212 | $633.55 | |
| 82533 | <1% | 78 | $630.29 | |
| 84520 | <1% | 307 | $587.64 | |
| 82378 | <1% | 70 | $575.55 | |
| 87070 | <1% | 107 | $549.48 | |
| 84681 | <1% | 57 | $542.23 | |
| 84270 | <1% | 43 | $447.11 | |
| 87328 | <1% | 69 | $412.98 | |
| 82670 | <1% | 26 | $404.55 | |
| 86703 | <1% | 30 | $360.74 | |
| 87329 | <1% | 69 | $359.69 | |
| 84154 | <1% | 34 | $282.35 | |
| 86625 | <1% | 46 | $250.18 | |
| 87427 | <1% | 46 | $228.79 | |
| 86705 | <1% | 26 | $180.22 | |
| 87045 | <1% | 46 | $173.88 | |
| 82248 | <1% | 55 | $139.23 | |
| 84702 | <1% | 13 | $133.03 | |
| 82150 | <1% | 12 | $67.03 | |
| 85379 | <1% | 12 | $43.93 | |
| 82947 | <1% | 13 | $18.37 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSYLAK, TOM (CHIEF OPERATING OFFICER)
Parent organizationTOLEDO CLINIC INCORPORTATED
| Provider | Location | Paid |
|---|---|---|
| Toledo Clinic Incorporated | Toledo, OH | $15.83M |
| Toledo Clinic Incorporated | Toledo, OH | $813K |
| Toledo Clinic Incorporated | Monroe, MI | $585K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.